FABP5 and metabolic dysfunction-associated steatohepatitis: Here we show that in each group of patients (NAFL, NASH borderline, and NASH) different patterns of gene expression were detected, as we observed that some patients had increased SPARC, CASP1, IL-1β, AKR1B10, and FABP5, while others showed decreased expression.